Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Radiologic Clinics of North America|October 6, 2022
Imaging of Smoking and Vaping Related Diffuse Lung InjuryKatherine A Cheng, Holly Nichols, H Page McAdams, et al.Annals of Diagnostic Pathology|April 12, 2015
Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sitesKatherine A Cheng, Boaz Kurtis, Sabina Babayeva, et al.Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 26, 2025
Multidisciplinary Approach to Familial Pulmonary FibrosisKatherine A Cheng, Rose McNulty, Holly Nichols, et al.Cancer Research|May 4, 2012
Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and METLu Xu, Eiki Kikuchi, Chunxiao Xu, et al.Cancer Research|March 29, 2014
Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancersAaron N Hata, Alan Yeo, Anthony C Faber, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2013
Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancerTakeshi Shimamura, Zhao Chen, Margaret Soucheray, et al.Nature Medicine|June 28, 2011
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibitionNeil Johnson, Yu-Chen Li, Zandra E Walton, et al.Cancer Cell|December 19, 2012
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer modelsRyan B Corcoran, Katherine A Cheng, Aaron N Hata, et al.Pageof 1